Technavio, a UK research company, released an analytic report on the intrauterine contraceptive devices (IUD) industry through 2027
The report says that the market size for IUD has been forecast to grow by $965 million for this period, with a CAGR of 3.98%. The growth of the market depends on several factors, including the increasing rate of unintended pregnancies and unwanted abortions, the initiatives by government and non-profit organizations, and the high growth of e-commerce platforms.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players.
The intrauterine contraceptive devices market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 vendors listed below, of which 0ne-third are located in India.
- Bayer AG, Germany
- DKT International, USA
- Durbin PLC, UK
- EurimPharm Arzneimittel GmbH, Germany
- EUROGINE SL, Spain
- Gima S.p.A., Italy
- HLL Lifecare Ltd., Kerala, India
- Krishco Medical Products Pvt. Ltd., Bangalore, India
- Laboratoire HRA Pharma SAS, France
- Melbea Innovations Ltd., Hungary
- Meril Life Sciences Pvt. Ltd., Gujarat, India
- Ocon Medical Ltd., Switzerland
- Pregna International Ltd., Gujarat, India
- Prosan International BV, Netherlands
- SMB Corp. Mumbai, India
Other snippets from the report:
- Based on type, the hormonal intrauterine device segment became the market’s largest segment in 2022.
- The adverse effects of IUDs are a major challenge to the global intrauterine contraceptive devices (IUD) market growth.
- The increasing number of unplanned pregnancies and unwanted abortions is the key factor driving the global intrauterine contraceptive devices (IUD) market growth.
- North America, will account for 33% of the market’s gowth during the forecast period. The U.S. leads the intrauterine contraceptive devices market in North America. The presence of local market players, supportive government initiatives, high awareness, and technological innovations such as postpartum and reusable IUDs drive market growth in the U.S.
Last updated: December 26th, 2025
